Key result
Angiotensin II and IV increased glucose-induced insulin release in INS-1 cells with a maximum effect at approximately 1 nM, and ANG IV reduced blood glucose increases during a tolerance test.
Answers are grounded in this paper and cite their sources.
Angiotensin II and IV stimulate insulin release via AT1 and AT4 receptors, suggesting a potential role for ANG IV/IRAP agonists in managing diabetic homeostasis.
The impact of angiotensin (ANG) for peripheral, global effects is well known. Local ANG systems including that of the insulin-releasing beta cell are not well investigated. In insulin-secreting cell line (INS-1), AT(1) and AT(4) receptors for ANG II and IV were demonstrated by Western blots. Only small amounts of ANG II-binding sites of low affinity were observed. ANG II and SARILE displaced binding of (125)I-ANG II. ANG II and IV as well as their non-degradable analogs SARILE and Nle-ANG IV increased the glucose-induced insulin release in a bell-shaped way; the maximum effect was at approximately 1 nM. The increase was antagonized by 1 microM losartan or 10 microM divalinal (AT(1) and AT(4) receptor antagonists, respectively). The insulin release was accompanied by a (45)Ca(2+) uptake in the case of ANG II and ANG IV. Divalinal abolished the effect of ANG IV and Nle-ANG IV on this parameter. ANG IV reduced the increase in blood glucose during a glucose tolerance test with corresponding, albeit smaller effects on plasma insulin. Using confocal laser scanning microscopy, transfected insulin-regulated aminopeptidase (IRAP) with AT(4) receptors was shown to be accumulated close to the nucleus and the cytosolic membrane, whereas GLUT4 was not detectable. IRAP was inhibited by ANG IV. In conclusion, AT(1) and AT(4) receptors may be involved in diabetic homeostasis. Effects are mediated by insulin release, which is accompanied by an influx of extracellular Ca(2+). The impact of ANG IV/IRAP agonists may be worth being used as antidiabetics.
No takes yet. Share an insight, caveat, or question.
Siebelmann et al. (2010) studied this question. Angiotensin II and IV was evaluated on Glucose-induced insulin release and blood glucose during a glucose tolerance test. Angiotensin II and IV increased glucose-induced insulin release in INS-1 cells with a maximum effect at approximately 1 nM, and ANG IV reduced blood glucose increases during a tolerance test.
Synapse has enriched 10 related papers. Consider them for comparative context: